Remove Genetic Analysis Remove Genetics Remove Protein
article thumbnail

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity This on-demand webinar introduces a cutting-edge single-cell multiomics method designed for garnering detailed genetic insights into breast cancer. The test accurately identified a range of genetic abnormalities, including trisomies and microdeletions.

Genetics 115
article thumbnail

AI test could predict best cancer therapies for patients

pharmaphorum

The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking at changes to 52 proteins when they are exposed to a panel of targeted anticancer drugs. The post AI test could predict best cancer therapies for patients appeared first on.

Protein 67
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Food and Beverage Industry Trends to Look Out for in 2021

XTalks

Plant proteins , milk alternatives , meat alternatives , bee-less honey , lab-grown meat and more are all kinds of innovations we have seen in 2020, but studies show that plant-based trends are still on the rise as new technologies are developed to cater to this market.

article thumbnail

4 Food and Beverage Industry Trends to Look Out for in 2021

XTalks

Plant proteins , milk alternatives , meat alternatives , bee-less honey , lab-grown meat and more are all kinds of innovations we have seen in 2020, but studies show that plant-based trends are still on the rise as new technologies are developed to cater to this market.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

RNA-Based Therapeutics RNA molecules have emerged as promising therapeutic agents due to their ability to precisely target undruggable proteins or molecules, often with minimal side effects. Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future. percent from 2022 to 2030.